CMM Treatment ApS: Financial statements 2022
CVR: 38553038
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
CMM Treatment ApS (CVR 38553038) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,750 and a net result of DKK -6,045 compared with DKK -5,850 the year before. Equity in the 2022 report amounted to DKK 26,796. The solvency ratio was 84.3%.
- Gross Profit
- DKK -7,750
- Profit/Loss
- DKK -6,045
- Equity
- DKK 26,796
- Total Assets
- DKK 31,796
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -8K | -6K | 27K | 0 |
| 2021 | - | -8K | -6K | 13K | 0 |
| 2020 | - | -8K | -6K | 19K | 0 |
| 2019 | - | -8K | -6K | 25K | - |
Official annual report
Keep an eye on CMM Treatment ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout CMM Treatment ApS
CMM Treatment ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CMM Treatment IVS. The management consists of Thomas Frilund Jacobsen. The company's owners include Marina Jacobsen, Martin Vetling and Claus Vetling. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -8,500 and a net result of DKK -8,500 compared with DKK -8,250 the year before. Equity in the 2025 report amounted to DKK -5,720.